Sudeep Pharma's ₹895 crore IPO has closed with an overwhelming subscription of 93.72 times. Strong demand, especially from Qualified Institutional Buyers (QIBs) subscribed 213 times, drove the issue. Investors are now eagerly awaiting the allotment status, expected today, November 26, 2025. Grey market indications suggest a potential listing gain of around 14.7%, with the stock slated to debut on November 28, 2025.